ஜீன் எரிக் சலாட்டா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜீன் எரிக் சலாட்டா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜீன் எரிக் சலாட்டா Today - Breaking & Trending Today

HUTCHMED Announces US$100 Million Equity Investment by Baring Private Equity Asia


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
HUTCHMED Announces US$100 Million Equity Investment by Baring Private Equity Asia
Hutchison China MediTech LimitedApril 8, 2021 GMT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 08, 2021 (GLOBE NEWSWIRE) Hutchison China MediTech Limited (“ HUTCHMED ”) (Nasdaq/AIM: HCM) today announces that it has entered into a definitive agreement for the issuance of US$100 million of shares at a price equivalent to US$30.5 per American Depositary Share (“ADS”) via a private placement to funds affiliated with Baring Private Equity Asia (“ BPEA ”). ....

United States , Hong Kong , City Of , United Kingdom , Mark Lee , Zhou Yi , Freddy Crossley Atholl Tweedie , Ben Atwell Alex Shaw , Jean Eric Salata , Christian Hogg , Annie Cheng , Financial Conduct Authority Disclosure Guidance , London Stock Exchange , London Stock Exchange Admission , Exchange Commission , European Union Withdrawal , Hutchison China Meditech Limited , China Meditech Limited , American Depositary Share , Baring Private Equity Asia , Chief Executive Officer , Founding Partner , Share Capital , Securities Act , European Union , Shares Outstanding After ,

Investegate |Hutchison China Medi Announcements | Hutchison China Medi: $100m Investment by Baring Private Equity Asia


 
 
Hong Kong, Shanghai & Florham Park, NJ - Thursday, April 8, 2021:
Hutchison China MediTech Limited ( HUTCHMED ) (Nasdaq/AIM: HCM) today announces that it has entered into a definitive agreement for the issuance of US$100 million of shares at a price equivalent to US$30.5 per American Depositary Share ( ADS ) via a private placement to funds affiliated with Baring Private Equity Asia ( BPEA ).
 
Mr. Christian Hogg, Chief Executive Officer of HUTCHMED, said, We expect significant growth of our business this year as we look to accelerate our oncology revenues from ELUNATE
®, SULANDA
® and the potential upcoming approval of savolitinib, likely to be a first-in-class selective c-MET inhibitor in China.  We are rapidly expanding global development of our ten oncology assets, all of which were discovered in-house at HUTCHMED, and are planning to initiate 8-10 registration and registration-intent studies in 2021 ....

United States , Hong Kong , City Of , United Kingdom , Mark Lee , Zhou Yi , Freddy Crossley Atholl Tweedie , Ben Atwell Alex Shaw , Jean Eric Salata , Christian Hogg , Annie Cheng , Financial Conduct Authority Disclosure Guidance , London Stock Exchange , London Stock Exchange Admission , Exchange Commission , European Union Withdrawal , Hutchison China Meditech Limited , Equity Investment , Florham Park , American Depositary Share , Baring Private Equity Asia , Chief Executive Officer , Founding Partner , Share Capital , Securities Act , European Union ,